Androgen deprivation therapy with agonists of GnRH: cardiovascular adverse events and comorbidity considerations in patients with prostate cancer

被引：0
|
作者：
Gritskevich, E. Y. U. [1 ]
Demidova, T. Y. U. [1 ]
机构：
[1] Pirogov Russian Natl Res Med Univ, Endocrinol, Moscow, Russia
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2847 / 2847
页数：1
相关论文
共 50 条
  • [1] ANDROGEN DEPRIVATION THERAPY AND ADVERSE CARDIOVASCULAR EVENTS IN MEN WITH PROSTATE CANCER
    Siu, Chung Wah
    Huang, Gang
    Tse, Hung-Fat
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1739 - E1739
  • [2] MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER PATIENTS WITH HYPERCHOLESTEROLEMIA/DIABETES
    Torres, Lindsay
    Boldt-Houle, Deborah
    Atkinson, Stuart
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [3] Major adverse cardiovascular events after androgen deprivation therapy in patients with prostate cancer with hypercholesterolemia.
    Twardowski, Przemyslaw
    Henry, Jacqueline
    Atkinson, Stuart
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [4] Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer
    Morgans, Alicia K.
    Shore, Neal
    Cope, Diane
    McNatty, Andrea
    Moslehi, Javid
    Gomella, Leonard
    Sartor, Oliver
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (01) : 52 - 62
  • [5] Incidence of Cardiovascular Events in Patients With Prostate Cancer and Treated With Androgen Deprivation Therapy
    Lowentritt, Benjamin
    Fallick, Mark
    Pruett, Janis
    Jiang, Tao
    Li, Eddie
    Brown, Bruce
    Dufour, Robert
    UROLOGY PRACTICE, 2024, 11 (01) : 154 - 161
  • [6] Patient Demographics and Major Adverse Cardiovascular Events after Androgen Deprivation Therapy for Prostate Cancer
    Wallis, Christopher J. D.
    Chen, Kevin C.
    Atkinson, Stuart
    Boldt-Houle, Deborah M.
    ADVANCES IN UROLOGY, 2024, 2024
  • [7] Risk of Cardiovascular Events Amongst Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
    Carelli, Eric
    Hulten, Edward
    Dragomir, Alice
    Boulet, Jacinthe
    Nadeau, Lyne
    Brophy, Jay
    Mousavi, Negar
    CIRCULATION, 2017, 136
  • [8] Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer. Differences between GnRH antagonists and GnRH agonists
    Tschoepe, C.
    Kherad, B.
    Spillmann, F.
    Schneider, C. A.
    Pieske, B.
    Krackhardt, F.
    HERZ, 2016, 41 (08) : 697 - 705
  • [9] Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events
    Krahn, M. D.
    Bremner, K. E.
    Luo, J.
    Alibhai, S. M. H.
    CURRENT ONCOLOGY, 2014, 21 (03) : E457 - E465
  • [10] Cardiovascular mortality in patients with prostate cancer exposed to androgen deprivation therapy
    Monzo-Gardiner, J. I.
    Herranz-Amo, F.
    ACTAS UROLOGICAS ESPANOLAS, 2015, 39 (08): : 518 - 522
12345